Eli Lilly LLY Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Eli Lilly’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Eli Lilly's change in AP?
- Eli Lilly (LLY) reported change in AP of $2.55B in Q4 2025.
- How has Eli Lilly's change in AP changed year-over-year?
- Eli Lilly's change in AP increased by 290.5% year-over-year, from $652.25M to $2.55B.
- What is the long-term trend for Eli Lilly's change in AP?
- Over 4 years (2021 to 2025), Eli Lilly's change in AP has grown at a 78.0% compound annual growth rate (CAGR), from -$1.01B to $10.19B.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.